NCT04369690 (C19Survey) is a clinical trial in COVID-19, sponsored by University of Ottawa.

Who is sponsoring NCT04369690?

NCT04369690 is sponsored by University of Ottawa.

What condition does NCT04369690 study?

NCT04369690 studies COVID-19, Chronic Disease, Psychiatric Disorder, Cardiovascular Diseases.

Is NCT04369690 still recruiting?

NCT04369690 is currently status unknown. Last updated 30 April 2020.

Last reviewed 2020-04-30 · How we verify

NCT04369690: C19Survey

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Psychological, Social, and Economic Impacts of COVID-19

Status unknown Last updated 30 April 2020

What this trial tests

trial in COVID-19 in 1,000 participants. Status unknown.

Timeline

3 April 2020

Primary endpoint
3 April 2021

3 April 2021

Quick facts

Lead sponsor	University of Ottawa
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	3 April 2020
Primary completion	3 April 2021
Estimated completion	3 April 2021
Sites	10 locations across Canada

Conditions studied

COVID-19 — all drugs for COVID-19 →
Chronic Disease — all drugs for Chronic Disease →
Psychiatric Disorder — all drugs for Psychiatric Disorder →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

University of Ottawa

Who can join

12 and older, any sex, with COVID-19 or Chronic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Profiles of sleep changes during the COVID-19 pandemic: Demographic, behavioural and psychological factors.
Robillard R, Dion K, Pennestri MH, Solomonova E, et al · · 2021 · cited 109× · PMID 33200477 · DOI 10.1111/jsr.13231
The new frontline: exploring the links between moral distress, moral resilience and mental health in healthcare workers during the COVID-19 pandemic.
Spilg EG, Rushton CH, Phillips JL, Kendzerska T, et al · · 2022 · cited 102× · PMID 34991514 · DOI 10.1186/s12888-021-03637-w
Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19.
Robillard R, Saad M, Edwards J, Solomonova E, et al · · 2020 · cited 92× · PMID 33310814 · DOI 10.1136/bmjopen-2020-043805
Emerging New Psychiatric Symptoms and the Worsening of Pre-existing Mental Disorders during the COVID-19 Pandemic: A Canadian Multisite Study: Nouveaux symptômes psychiatriques émergents et détérioration des troubles mentaux préexistants durant la pandémie de la COVID-19: une étu
Robillard R, Daros AR, Phillips JL, Porteous M, et al · · 2021 · cited 72× · PMID 33464115 · DOI 10.1177/0706743720986786
Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD.
Murkar A, Kendzerska T, Shlik J, Quilty L, et al · · 2022 · cited 13× · PMID 35978287 · DOI 10.1186/s12888-022-04185-7
SARS-Cov-2 Damage on the Nervous System and Mental Health.
Boulkrane MS, Ilina V, Melchakov R, Arisov M, et al · · 2022 · cited 4× · PMID 34191699 · DOI 10.2174/1570159x19666210629151303
Changes in Positive Airway Pressure Use in Adults with Sleep-Related Breathing Disorder During the COVID-19 Pandemic: A Cross-Sectional National Community-Based Survey.
Kendzerska T, Saad M, Ayas N, Robillard R. · · 2022 · cited 1× · PMID 35692865 · DOI 10.1007/s41782-022-00207-2
The New Frontline: Exploring the Links between Moral Distress, Moral Resilience and Mental Health in Healthcare Workers Amidst the COVID-19 Pandemic
Spilg E, Rushton CH, Phillips JL, Kendzerska T, et al · · 2021 · cited 1× · DOI 10.2139/ssrn.3820558

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other University of Ottawa trials

Trials by the same sponsor.

NCT07459465 — Postprandial Triglyceride Concentrations Across Menstrual Cycle Phases · NA · not yet recruiting
NCT07261202 — Impact of Indoor Overheating on Physiological Strain in Children · NA · recruiting
NCT07383324 — Heat Stress in Individuals With Schizophrenia · NA · recruiting
NCT07267598 — Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults · NA · recruiting
NCT07189507 — Suitability of the 26 °C Indoor Temperature Upper Limit for Older Adults: Impacts of Clothing and Daily Activity · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04369690 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ottawa
Last refreshed: 30 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04369690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing